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Background-—Lower muscle mitochondrial energy production may contribute to impaired walking endurance in patients with
peripheral arterial disease. A borderline ankle-brachial index (ABI) of 0.91 to 1.10 is associated with poorer walking endurance
compared with higher ABI. We hypothesized that in the absence of peripheral arterial disease, lower ABI is associated with lower
mitochondrial energy production.
Methods and Results-—We examined 363 men and women participating in the Baltimore Longitudinal Study of Aging with an ABI
between 0.90 and 1.40. Muscle mitochondrial energy production was assessed by post-exercise phosphocreatine recovery rate
constant (kPCr) measured by phosphorus magnetic resonance spectroscopy of the left thigh. A lower post-exercise
phosphocreatine recovery rate constant reflects decreased mitochondria energy production.The mean age of the participants
was 7112 years. A total of 18.4% had diabetes mellitus and 4% were current and 40% were former smokers. Compared with
participants with an ABI of 1.11 to 1.40, those with an ABI of 0.90 to 1.10 had significantly lower post-exercise phosphocreatine
recovery rate constant (19.3 versus 20.8 ms1, P=0.015). This difference remained significant after adjusting for age, sex, race,
smoking status, diabetes mellitus, body mass index, and cholesterol levels (P=0.028). Similarly, post-exercise phosphocreatine
recovery rate constant was linearly associated with ABI as a continuous variable, both in the ABI ranges of 0.90 to 1.40
(standardized coefficient=0.15, P=0.003) and 1.1 to 1.4 (standardized coefficient=0.12, P=0.0405).
Conclusions-—An ABI of 0.90 to 1.10 is associated with lower mitochondrial energy production compared with an ABI of 1.11 to
1.40. These data demonstrate adverse associations of lower ABI values with impaired mitochondrial activity even within the range
of a clinically accepted definition of a normal ABI. Further study is needed to determine whether interventions in persons with ABIs
of 0.90 to 1.10 can prevent subsequent functional decline. ( J Am Heart Assoc. 2017;6:e006604. DOI: 10.1161/JAHA.117.
006604.)
Key Words: aging • ankle-brachial index • mitochondrial function
I n peripheral arterial disease (PAD), clinically defined as anankle-brachial index (ABI) <0.90, chronically reduced blood
flow to the lower extremities is associated with reduction in
walking endurance.1 Limited walking endurance is associated
with lower mitochondrial energy production,2–4 which is
attributed to impaired oxygen delivery5 as well as intrinsic
mitochondrial myopathy resulting from the repeated cycles of
ischemia/reperfusion injury.6
Growing literature also suggests that compared with those
with a normal ABI (1.1–1.4), individuals with borderline ABI
(0.90–0.99) and low normal ABI (1.00–1.09) are also more
likely to have poor walking endurance, possibly attributable to
subclinical atherosclerosis.7–9 Whether poorer walking per-
formance previously observed in this group is also associated
with impaired leg muscle mitochondrial function is unknown.
We hypothesize that as is the case in PAD with ABI <0.90,
an ABI of 0.90 to 1.10 is also associated with lower leg
muscle mitochondrial energy production compared with an
ABI of 1.11 to 1.40. To test this hypothesis, we examined the
association between ABI and mitochondrial energy produc-
tions, assessed by phosphorus magnetic resonance
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spectroscopy (31P-MRS), in participants of the BLSA (Balti-
more Longitudinal Study of Aging), free of clinically overt PAD.
Methods
Sample
We analyzed data from 363 men and women participating in
the BLSA with ABIs between 0.90 and 1.40, who underwent
post-exercise phosphocreatine recovery rate (kPCr) measure-
ment via 31P-MRS of the thigh muscle and ABI testing.
Participants were divided in 2 groups: those with an ABI of
0.90 to 1.09 and those with an ABI of 1.10 to 1.40. The
overall design, study population, and measurement protocols
of the BLSA have been previously reported.10 Briefly, the
BLSA, established in 1958, is a continuous enrollment cohort
study of community-dwelling adults conducted by the National
Institute on Aging Intramural Research Program. Participants
with no major chronic conditions or functional impairments
are enrolled in the study and follow-up visits occur at intervals
of 1 to 4 years, becoming more frequent for older partici-
pants. Trained and certified technicians administered all of the
assessments, following standardized protocols. The institu-
tional review board of the National Institute of Environmental
Health Sciences approved the study protocol, and all partic-
ipants gave written informed consent.
Ankle-Brachial Index
Simultaneous bilateral brachial and ankle blood pressure (BP)
measurements were performed as part of the routine
diagnostic procedure to assess bilateral ABI using the
oscillometric technique. After a 10-minute resting period in
the supine position, patients underwent 3 repeated BP
measurements of both ankles and both arms taken
simultaneously using a validated automatic oscillometric
device (Colin VP-2000; Colin Medical Technology). BP cuffs
were applied to the arms and ankles of patients and BP was
recorded in triplicates. The ABI was calculated as the average
of the triplicate readings of resting ankle systolic pressure of
the index leg divided by the average of the left and right arm
resting brachial systolic pressure readings. We used left ABI
for the primary analysis given that muscle spectroscopy was
performed on the left thigh muscles; an alternative analysis
was performed using the right ABI to examine for the
specificity of the association with the ipsilateral readings.
31P-Magnetic Resonance Spectroscopy
Skeletalmusclemitochondrial energy productionwasmeasured
using a previously described MRI method.11 In vivo spectra of
phosphorous-containing metabolites were acquired using a 3T
Philips Achieva MR scanner (Philips) and a 10-cm 31P-tuned
surface coil (PulseTeq) fastened over the left thigh vastus
lateralis muscle. Participants performed a rapid ballistic knee
extension exercise while lying supine in the bore of the magnet;
this maneuver was practiced before entering the magnet.11,12 A
series of pulse-acquire 31P spectra were obtained before,
during, and after the knee extension exercise. The pulse
sequence consisted of adiabatic radiofrequency excitation
pulses with a 90-degree flip angle, for 300 acquisitions, with a
repetition time of 1.5 seconds; signal averaging over 4 succes-
sive acquisitions for signal-to-noise ratio enhancement, gave
effectively 75 spectra obtained with a temporal resolution of
6 seconds. The length of exercise was monitored to achieve
between a 33% to 66% reduction in phosphocreatine (PCr) peak
height (and never exceeded 42 seconds), with a post-exercise
recovery period of 5.8 to 6.3 minutes. Spectra were processed
using jMRUI (version 5.0), andmetaboliteswere quantified using
a nonlinear least-squares algorithm (AMARES).13,14
Skeletal muscle oxidative ATP resynthesis rate
determined by 31P-MRS
The recovery rate for phosphocreatine was calculated by
fitting the post-exercise time-dependent change in PCr to a
mono-exponential function of the form:
PCr ðtÞ ¼ PCr0þ DPCr ð1 exp ðt=sPCrÞÞ
where PCr0 is the end-of-exercise PCr signal area (ie, the PCr
signal area at the beginning of the recovery period), DPCr is the
decrease in signal area from its pre-exercise baseline value of
PCrbaseline to PCr0 resulting from in-magnet exercise, and
sPCr is the PCr exponential recovery time constant. The inverse
of sPCr, kPCr (=1/sPCr) is thus the recovery rate constant.
Greater kPCr reflects shorter recovery time, and hence higher
mitochondrial energy production. This is taken as an index of
Clinical Perspective
What Is New?
• Borderline and low normal ankle-brachial index values are
associated with reduced thigh muscle energy production in
people free of overt cardiovascular disease
• This supports evidence that mildly reduced ankle-brachial
index values are associated with adverse mitochondrial
characteristics.
What Are the Clinical Implications?
• Future study is needed to determine whether interventions
that improve lower extremity perfusion or increase mito-
chondrial activity can prevent functional decline in persons
with an ankle-brachial index of 0.90 to 1.40.
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in vivo muscle oxidative phosphorylation capacity, as there are
minimal other energy demands during this resting period. kPCr
resynthesis is primarily considered a function of maximum
mitochondrial ATP productionwith no orminimal contribution of
anaerobic metabolism.15–20 The percentage of PCr depletion
was calculated as the decrease in the PCr peak area from pre-
exercise PCrbaseline to PCr0.21,22 Intramuscular pH was also
monitored (calculated according to the chemical shift of
inorganic phosphate, Pi, relative to PCr) to ensure that
intramuscular pH did not drop below 6.80.23
Clinical Variables
Height and weight were objectively measured per standard
protocols. Body mass index was determined as kilograms per
square meter. Patients were classified as current, former, or
never smokers. The use of medications was determined at
each study visit. Diabetes mellitus was defined as meeting
2011 American Diabetes Association criteria24 or the use of
diabetes mellitus medications. Hypercholesterolemia was
defined as a total serum cholesterol level of 200 mg/dL or
the use of lipid-lowering treatment.
Laboratory Studies
Fasting plasma glucose, triglyceride, total cholesterol, and
high-density lipoprotein cholesterol levels were measured.
Low-density lipoprotein cholesterol concentrations were esti-
mated using the Friedewald formula.25
Statistical Analyses
Descriptive characteristics and kPCr values were compared
between participants with an ABI of 0.90 to 1.10 and those with
an ABI of 1.11 to 1.40 using Student t test and chi-square
statistics. Bivariate correlation between kPCr and left and right
ABIs was performed to examine the specificity of the associ-
ation between left thigh kPCr with ipsilateral versus contralat-
eral ABI. To test whether the difference in kPCr between the 2
groups was independent of other covariates, we used general
linear models with ABI as a categorical variable (ie, ABI 0.90–
1.10 versus ABI 1.11–1.40) to compute and compare the least-
square means (marginal means) of kPCr for both categories
adjusting for age, sex, race, smoking status, diabetes mellitus,
hypertension, body mass index, and cholesterol levels. To
examine whether the association between ABI and kPCr
displays a threshold effect or whether it persists in an ABI
range of 1.11 to 1.40, we fit linear regression models, using
kPCr and ABI as continuous variables, in the larger ABI range of
0.90 to 1.40 and limited to the group with an ABI of 1.11 to
1.40. ABI was entered as a quadratic term to test for
nonlinearity in the association and removed from the model
when nonsignificant. All analyses were performed with SAS for
Windows (version 9.3; SAS Institute Inc).
Results
Descriptive characteristics are shown on Table 1. The sample
included363participantswith ameanage of 7112 years; 18%
of the participants had diabetes mellitus and 3.2% were current
and 36.9% were former smokers. A total of 37% depletion of PCr
was observed with exercise with a recovery rate constant (kPCr)
of 20.6 ms1. These findings are consistent with reports from
similar populations.16,26 The average ABI was 1.160.08, with
82 participants (22%) having ABI of 0.90 to 1.10. Comparedwith
participants with an ABI of 1.11 to 1.40, those with an ABI of
0.90 to 1.11 included a higher prevalence ofwomen (73% versus
54.1%, P=0.001) and had slower PCr recovery (19.3 versus
20.8 ms1, P=0.015), with no difference in percentage of PCr
depletion. Interestingly, while left and right ABI were strongly
correlated (r=0.75, P<0.001), kPCr was significantly correlated
with the ipsilateral, left ABI (r=0.12, P=0.003); however, the
association was weaker and marginally significant with the
contralateral ABI (r=0.075, P=0.073) (Table 2). The rest of
the analysis was performed using left ABI, referred to simply as
ABI. Figure 1 shows that the difference in kPCr between the 2
groups remained significant using least-square means adjusted
for age, sex, race, diabetes mellitus, smoking status, body mass
index, mean brachial BP, and cholesterol levels. There was no
significant interaction between sex and ABI in the association
with kPCr (data not shown).
To examine whether the association between ABI and kPCr
has a threshold effect, we performed bivariate and multivari-
ate linear regression analysis predicting kPCr among partic-
ipants with an ABI of 0.90 to 1.40 and among those with an
ABI of 1.10 to 1.40. ABI was linearly associated with kPCr in a
bivariate analysis (Figure 2). Similarly, multivariate analysis
showed that ABI was significantly associated with kPCr
(standardized coefficient [B]=0.15, P=0.0027) adjusting for
the covariates mentioned above (Table 3). The association
was linear across the ABI range of 0.90 to 1.40, evidenced by
the nonsignificant quadratic term for ABI in the model (data
not shown). The association between ABI and kPCr remained
significant when the analysis was restricted to the ABI range
of 1.11 to 1.40 (Table 3).
Discussion
Main Findings
This analysis shows a statically significantly lower muscle
mitochondrial energy production in persons with a modestly
reduced ABI of 0.90 to 1.09 compared with those with an ABI
of 1.10 to 1.40. These findings suggest the possibility that a
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modestly lower ABI in the absence of overt PAD may have a
negative association with mitochondria function. Interestingly,
in this study, the positive association between ABI and lower
muscle energy production was linear along the entire ABI
range of 1.10 to 1.40.
Lower ABI is Linearly Associated With Reduced
Mitochondrial Energy Production
These findings expand on previous reports showing a
significant reduction in mitochondrial energy production in
patients with PAD2–4 and suggest that even modest alter-
ations in lower extremity perfusion may cause reduced
muscle mitochondrial energy production.
The mechanism that links ABI with muscle mitochondrial
energetics is not clear. There is a debate on whether the
Table 2. Correlation Matrix
Age kPCr Left ABI Right ABI
Age 1 0.30731* 0.05338 0.0092
kPCr 1 0.12282† 0.07587
Left ABI 1 0.75336*
Right ABI 1
ABI indicates ankle-brachial index; kPCr, post-exercise phosphocreatine recovery rate















Figure 1. Least-square means and standard errors of post-
exercise phosphocreatine recovery rate constant (kPCr) in patients
with an ankle-brachial index (ABI) 0.9 to 1.1 (black bar) and patients
with an ABI>1.1 (white bar), adjusting for age, sex, race, diabetes
mellitus, smoking, and body mass index.
Table 1. Descriptive Characteristics
Variable
Total (N=363) ABI 0.9 to 1.01 (n=82) ABI 1.1 to 1.4 (n=281)
P ValueMeanSD, No. (%)
Age 71.012.7 71.914.8 71.312.1 0.7027
Women 212 (58.4) 60 (73.2) 152 (54.1) 0.0012
White race 247 (68.0) 56 (68.3) 191 (67.9) 0.6864
Smoking 0.7967
Never 206 (59.9) 48 (61.5) 161 (59.1)
Former 127 (36.9) 28 (35.9) 101 (37.6)
Current 11 (3.2) 2 (2.6) 10 (3.3)
Left ABI 1.160.08 1.050.04 1.190.06 <0.0001
kPCr, ms1 20.60.005 19.35.6 20.84.7 0.0146
PCr depletion, % 37.711.1 37.511.0 37.511.1 0.9640
Brachial SBP 119.314.4 120.316.2 119.514.3 0.6809
Hypertension 135 (38.9) 30 (39.5) 105 (38.8) 0.7059
Hypertension treatment 122 (90.0) 28 (93.0) 94 (89.5) 0.4564
Diabetes mellitus 64 (18.4) 11 (14.5) 53 (19.6) 0.6117
Glucose, mg/dL 90.4416.4 91.425.2 90.112.8 0.5055
LDL cholesterol, mg/dL 98.731.7 103.632.9 97.031.4 0.1006
HDL cholesterol, mg/dL 62.717.8 63.118.1 62.617.6 0.8578
Total cholesterol, mg/dL 180.236.8 185.637.1 178.436.6 0.1235
BMI, kg/m2 29.74.1 26.44.2 26.84.1 0.4083
ABI indicates ankle-brachial index; BMI, body mass index; HDL, high-density lipoprotein; kPCr, post-exercise phosphocreatine recovery rate constant of the thigh muscle; LDL, low-density
lipoprotein; PCr, phosphocreatine recovery rate constant; SBP, systolic blood pressure.
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reduced mitochondrial energy production in PAD is a result of
decreased perfusion and oxygen delivery during exercise or
results from intrinsic mitochondrial impairment caused by
repetitive cycles of ischemia-reperfusion injury.2 Decreased
perfusion via cuff-induced stenosis causes a reduction in post-
exercise mitochondrial energy production in healthy men and
women, supporting the notion that reduced oxygen delivery
during exercise affects mitochondrial function.5 Further
studies with assessment of leg arterial anatomy and flow
are needed to examine whether a modest reduction in ABI is a
result of subclinical flow limiting lesion in arteries of the lower
extremities.
An additional explanation of the linear association between
ABI and mitochondrial function within the “normal” range is
that a modest reduction in ABI is a marker of arterial stiffness,
which has been associated with universal organ dysfunction
with aging, and not restricted to the legs. A normal ABI (1.10–
1.40) reflects physiologic pulse pressure amplification, ie,
higher systolic BP, in distal versus proximal arterial sites.8,27
This phenomena is caused by the stiffer peripheral versus
central arteries and by wave reflection hemodynamics that
amplify pressure to a greater extent in distal versus proximal
arterial sites. Given the profound central arterial stiffening and
alterations to wave reflection dynamics with aging,28 periph-
eral amplification and subsequently ABI are reduced. Hence, a
modest reduction in ABI within the range of 1.1 to 1.4 could
also be a marker of central arterial stiffness, and not
necessarily a reflection of limb-specific flow impairment.
Further studies with a larger sample size and repeated
measures are needed to examine whether measures of
arterial stiffness and pulse pressure amplification explain the
association between ABI and mitochondrial energy production
and functional capacity.
Reduced Mitochondrial Energy Production as a
Potential Link Between Low ABI and Impaired
Walk Endurance
McDermott et al29 have shown that an ABI between 0.90 and
1.10 was associated with reduced functional capacity
Table 3. Linear Regression Model Predicting kPCr
ABI 0.9 to 1.4 (N=363) ABI 1.1 to 1.4 (N=281)
b B* P Value b B† P Value
Age 0.13 0.28 <0.0001 0.14 0.37 <0.0001
Men 0.46 0.04 0.3484 0.93 0.09 0.1334
White race 1.91 0.16 0.0011 1.19 0.12 0.0492
PCr depletion, % 0.13 0.29 <0.0001 0.12 0.29 <0.0001
ABI 8.4 0.15 0.0027 9.0 0.12 0.0405
Smoking, ever 0.11 0.01 0.8146 0.14 0.018 0.7565
Diabetes mellitus 0.01 0.001 0.9982 0.36 0.03 0.6069
BMI, kg/m2 0.03 0.03 0.5622 0.04 0.04 0.5711
HR, beats per min 0.06 0.11 0.0202 0.06 0.10 0.0705
MAP, mm Hg 0.03 0.08 0.085 0.04 0.08 0.1453
LDL cholesterol, mg/dL 0.01 0.05 0.2847 0.01 0.08 0.1563
HDL cholesterol, mg/dL 0.01 0.04 0.4700 0.01 0.04 0.5549
Triglycerides, mg/dL 0.006 0.05 0.3141 0.006 0.06 0.3194
ABI indicates ankle brachial index; BMI, body mass index; HDL, high-density lipoprotein; HR, heart rate; kPCr, post-exercise phosphocreatine recovery rate constant of the thigh muscle;
LDL, low-density lipoprotein; MAP, mean arterial pressure; PCr, phosphocreatine recovery rate constant.
*Β, nonstandardized coefficients.















Figure 2. Linear regression analysis showing the association
between post-exercise phosphocreatine recovery rate constant
(kPCr) of the thigh muscle with ankle-brachial index.
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measured by 6-meter walking speed. Furthermore, an ABI of
0.90 to 1.10 was prospectively associated with a greater
decline in 6-minute walk performance as well as a greater risk
for developing mobility loss over 5 years, when compared
with an ABI of 1.11 to 1.40.9 These findings suggest that a
gradual decline in ABI may be a marker of subclinical
atherosclerotic disease in the lower extremities as well as
in other organs that cumulatively affect lower extremity
performance.8
Our findings suggest that a possible modest restriction of
blood flow with lower ABI could potentially compromise
muscle mitochondrial function and directly contribute to
poorer walking function in this group. We have previously
reported, using data from the same cohort, that reduced
mitochondrial energy production was associated with less
exercise endurance, assessed by 400-meter walking speed.30
Future studies are needed to demonstrate whether modest
reduction of ABI when associated with impaired mitochondrial
function predicts the risk of developing overt PAD. In addition,
our findings raise the question of whether persons with ABIs
of 0.90 to 1.10 would benefit from interventions aimed at
preventing further mitochondrial damage and, therefore, its
functional consequences and perhaps even full development
of PAD.
Strengths and Limitations
To our knowledge, this is the first study to examine the
relationship between skeletal muscle mitochondrial energy
production assessed by 31P-MRS of thigh muscle and ABI
over the range of ABI of 0.90 to 1.40. However, it is important
to consider the study limitations. This is a cross-sectional
analysis; hence, inferences regarding causality cannot be
made. The design of the BLSA prevented the inclusion of
participants with PAD, which would have provided a wider
range of ABI and kPCr. However, we believe that this topic has
been studied in a PAD population, making the findings of this
report complementary to those previously reported.
In addition, the magnitude of difference between the 2
groups is smaller compared with that reported between
normal and PAD. While this is expected, it raises questions
about the clinical relevance of these findings. We have
previously reported, using data from this cohort, that kPCR
was strongly associated with 400-meter walking speed,30
which suggests that even such variations in this normal range
might underlie subclinical alterations in function. We are in
the process of collecting longitudinal data of ABI, mitochon-
drial function, and walking endurance from a larger sample,
which will allow further elaboration on these findings.
Another limitation of our study is that mitochondrial testing
was performed on the thigh muscle. This is likely to be affected
only by proximal flow limitation compared with calf muscles,
which are more frequently involved. Last, we measured ABI
using the oscillometric rather than the auscultatory technique.
This technique does not provide separate tibial and peroneal
measures. However, the oscillometric technique has the clear
advantage of being less operator dependent.
Perspectives
An ABI of 0.91 to 1.10 is associated with reduced mitochon-
drial energy production. The association between lower ABI
and reduced mitochondrial energy production is also evident
in the normal ABI range of 1.11 to 1.40. Further studies are
needed to examine whether this subclinical decline in
mitochondrial energy production is associated with future
decline in walking endurance and the development of PAD
symptomatology.
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